10 min

Ivermectin for Mild to Moderate COVID-19, Persistent Symptoms Following COVID-19, Review of Hypercalcemia, and more JAMA Editors' Summary

    • Medicine

Editors' Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 25, 2022, issue.

Editors' Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 25, 2022, issue.

10 min

More by JAMA